Cargando…
Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab
Autores principales: | Zhao, Patricia, Rusu, Corina A., Schenck, Olivia L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015770/ https://www.ncbi.nlm.nih.gov/pubmed/37034027 http://dx.doi.org/10.1016/j.jdcr.2023.03.003 |
Ejemplares similares
-
Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
por: Hanfstingl, Kathrin, et al.
Publicado: (2018) -
Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination
por: Liu, Ya‐ting, et al.
Publicado: (2022) -
Successful treatment of type I pityriasis rubra pilaris with ixekizumab
por: Heibel, Mark D., et al.
Publicado: (2018) -
Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient
por: Kranyak, Allison, et al.
Publicado: (2022) -
Photosensitive pityriasis rubra pilaris
por: Męcińska-Jundziłł, Kaja, et al.
Publicado: (2016)